Lakefront Biotherapeutics | GLPG - Рыночная капитализация





Рыночная капитализация Изменить Дата
argenx SE USD 39.98B 4.4B 2026-05
AstraZeneca USD 301.25B 13.1B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
GRIFOLS EUR 3.69B 1.9B 2026-05
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Incyte USD 21.73B 3B 2026-05
Merck EUR 51.28B 4.5B 2026-05
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Novartis USD 232.75B 75B 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05